BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30614440)

  • 1. The clinical and pathological features of adefovir dipivoxil-related renal impairment
.
    Lv Y; Li X; Liang S; Liang D; Xu F; Zhu X; Zeng C
    Clin Nephrol; 2019 Mar; 91(3):180-186. PubMed ID: 30614440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies.
    Izzedine H; Hulot JS; Launay-Vacher V; Marcellini P; Hadziyannis SJ; Currie G; Brosgart CL; Westland C; Arterbrun S; Deray G; ;
    Kidney Int; 2004 Sep; 66(3):1153-8. PubMed ID: 15327411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal histology of Fanconi syndrome associated with adefovir dipivoxil: A case report.
    Xu S; Ni H; Wu M; Xie X; Liu B; Zhang X; Liu H
    Clin Nephrol; 2024 Feb; 101(2):93-98. PubMed ID: 38032142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B.
    Shimizu M; Furusyo N; Ikezaki H; Ogawa E; Hayashi T; Ihara T; Harada Y; Toyoda K; Murata M; Hayashi J
    World J Gastroenterol; 2015 Feb; 21(7):2116-23. PubMed ID: 25717246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B.
    Gara N; Zhao X; Collins MT; Chong WH; Kleiner DE; Jake Liang T; Ghany MG; Hoofnagle JH
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1317-25. PubMed ID: 22506503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.
    Herlitz LC; Mohan S; Stokes MB; Radhakrishnan J; D'Agati VD; Markowitz GS
    Kidney Int; 2010 Dec; 78(11):1171-7. PubMed ID: 20811330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B.
    Tanaka M; Suzuki F; Seko Y; Hara T; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
    J Gastroenterol; 2014 Mar; 49(3):470-80. PubMed ID: 23525978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose adefovir dipivoxil may induce Fanconi syndrome: clinical characteristics and long-term follow-up for Chinese patients.
    Xu LJ; Jiang Y; Liao RX; Zhang HB; Mao JF; Chi Y; Li M; Wang O; Liu XQ; Liu ZY; Xing XP; Yu W; Xia WB
    Antivir Ther; 2015; 20(6):603-11. PubMed ID: 25814481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series.
    Chen N; Zhang JB; Zhang Q; Zhao YP; Li LY; Liu LW; Yu F; Yu X; Peng T; Tang KX
    BMC Pharmacol Toxicol; 2018 May; 19(1):23. PubMed ID: 29769119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose adefovir dipivoxil-induced hypophosphatemia osteomalacia in five chronic hepatitis B virus-infected patients. Is low-dose adefovir dipivoxil-induced nephrotoxicity completely reversible?
    Qian YY; Dai ZJ; Ruan LY; Pan YJ; Jin J; Shi MT; Zhu YX; Wu CM
    Drug Des Devel Ther; 2019; 13():1127-1133. PubMed ID: 31118563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypophosphatemic osteomalacia and renal Fanconi syndrome induced by low-dose adefovir dipivoxil: a case report and literature review suggesting ethnic predisposition.
    Wu C; Zhang H; Qian Y; Wang L; Gu X; Dai Z
    J Clin Pharm Ther; 2013 Aug; 38(4):321-6. PubMed ID: 23590583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil.
    Ha NB; Ha NB; Garcia RT; Trinh HN; Vu AA; Nguyen HA; Nguyen KK; Levitt BS; Nguyen MH
    Hepatology; 2009 Sep; 50(3):727-34. PubMed ID: 19517525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early kidney injury during long-term adefovir dipivoxil therapy for chronic hepatitis B.
    Jia HY; Ding F; Chen JY; Lian JS; Zhang YM; Zeng LY; Xiang DR; Yu L; Hu JH; Yu GD; Cai H; Lu YF; Zheng L; Li LJ; Yang YD
    World J Gastroenterol; 2015 Mar; 21(12):3657-62. PubMed ID: 25834334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired Fanconi syndrome associated with prolonged adefovir dipivoxil therapy in a chronic hepatitis B patient.
    Law ST; Li KK; Ho YY
    Am J Ther; 2013; 20(6):e713-6. PubMed ID: 21519215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus.
    Tamori A; Enomoto M; Kobayashi S; Iwai S; Morikawa H; Sakaguchi H; Habu D; Shiomi S; Imanishi Y; Kawada N
    J Viral Hepat; 2010 Feb; 17(2):123-9. PubMed ID: 19674281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug safety evaluation of adefovir in HBV infection.
    Viganò M; Lampertico P; Colombo M
    Expert Opin Drug Saf; 2011 Sep; 10(5):809-18. PubMed ID: 21671843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy.
    Lee M; Oh S; Lee HJ; Yeum TS; Lee JH; Yu SJ; Kim HY; Yoon JH; Lee HS; Kim YJ
    J Viral Hepat; 2014 Dec; 21(12):873-81. PubMed ID: 24351112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotoxicity, including acquired Fanconi's syndrome, caused by adefovir dipivoxil - is there a safe dose?
    Law ST; Li KK; Ho YY
    J Clin Pharm Ther; 2012 Apr; 37(2):128-31. PubMed ID: 21714795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Compare the effect of combined therapy between telbivudine plus adefovir dipivoxil and lamivudine plus adefovir dipivoxil corresponding to renal function in patients with hepatitis B virus infection].
    Xu J; Bao L; Wang Y; Yang L; Li WT; Zhao ZH; Li Y
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):288-293. PubMed ID: 29996341
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study.
    Maggi P; Montinaro V; Leone A; Fasano M; Volpe A; Bellacosa C; Grattagliano V; Coladonato L; Lapadula G; Santantonio T; Angarano G
    J Antimicrob Chemother; 2015 Apr; 70(4):1150-4. PubMed ID: 25525197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.